Clinical Trial Update: DNA Vaccine Therapy in Treating Patients With Chronic Hepatitis C Virus Infection [Phase 1]

View source ↗

Summary

This document reports a Phase 1 clinical trial evaluating a DNA vaccine therapy for chronic hepatitis C virus infection. The study is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C
• Hepatocellular Carcinoma

Drugs mentioned

• DNA vaccine therapy (DNA vaccine)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Chronic Hepatitis, Hepatitis C Infection | Phase 1 | Status: ACTIVE_NOT_RECRUITING